Skip to content

Global multi-center study of a disposable duodenoscope

Global Prospective Case Series using a Single-Use Duodenoscope

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036150
Enrollment
1000
Registered
2021-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: ERCP or other duodenoscope based procedure completed with EXALT Model D Duodenoscope.: A duodenoscope will be guided through the mouth, esophagus, stomach to the duodenum. Accessories a

Sponsors

Boston Scientific Corporation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 18 years or older 2. Willing and able to comply with the study procedures and provide written informed consent to participate in the study 3. Scheduled for a clinically indicated ERCP or other duodenoscope-based procedure

Exclusion criteria

Exclusion criteria: 1. Potentially vulnerable subjects, including, but not limited to pregnant women 2. Subjects for whom endoscopic techniques are contraindicated 3. Subjects who are currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor 4. Investigator discretion

Design outcomes

Primary

MeasureTime frame
Ability to complete the ERCP or other duodenoscope-based procedure for the intended indication(s)Timepoint: Ability to complete the procedure is assessed at the end of the procedure on study day 1

Secondary

MeasureTime frame
Document endoscopist rating of the Exalt single-use duodenoscope compared to marketed reusable duodenoscopes as it pertains to various design and performance related attributesTimepoint: Assessed at the end of the procedure on study day 1;Evaluation of serious adverse events (SAEs) related to the device and/or the procedure through 30 days after the ERCP or duodenoscope-based procedureTimepoint: Assessed on study day 30;Incidence of crossover from Exalt single-use duodenoscope to reusable duodenoscopeTimepoint: Assessed at the end of the procedure on study day 1

Countries

Canada, France, Germany, Hong Kong, India, Italy, Netherlands, United States of America

Contacts

Public ContactD Nageshwar Reddy

Asian Institute of Gastroenterology

aigindiainfo@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026